Sat.Sep 23, 2023

article thumbnail

#ScienceSaturday: September 23, 2023

KIF1A

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors During the COVID-19 epidemic many of us experienced how devastating shipping disruptions were; industri

article thumbnail

Talking to a Loved One Battling Substance Abuse: Staying Positive Is Key

Drugs.com

SATURDAY, Sept. 23, 2023 -- A conversation with a family member or loved one struggling with addiction can be the catalyst for getting help. But it’s important to choose your words carefully when discussing possible addiction to controlled.

81
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent expiration for Paratek Pharms drug NUZYRA

Drug Patent Watch

Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. It is available from one supplier. There are ten… The post New patent expiration for Paratek Pharms drug NUZYRA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

Which pharmaceutical companies have the most drug patents in Greece?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Greece. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Greece? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.